CN101530526A - External Chinese medicament for treating hyperosteogeny and lumbar interveterbral disc protrusion - Google Patents
External Chinese medicament for treating hyperosteogeny and lumbar interveterbral disc protrusion Download PDFInfo
- Publication number
- CN101530526A CN101530526A CN200910011303A CN200910011303A CN101530526A CN 101530526 A CN101530526 A CN 101530526A CN 200910011303 A CN200910011303 A CN 200910011303A CN 200910011303 A CN200910011303 A CN 200910011303A CN 101530526 A CN101530526 A CN 101530526A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- external chinese
- hyperosteogeny
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 13
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 claims description 16
- 208000012287 Prolapse Diseases 0.000 claims description 10
- 241001489978 Eupolyphaga Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 8
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000004744 fabric Substances 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 201000004595 synovitis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an external Chinese medicament for treating diseases such as hyperosteogeny and lumbar interveterbral disc protrusion, and belongs to external Chinese medicament. The external Chinese medicament for treating the hyperosteogeny and the lumbar interveterbral disc protrusion has good curative effect and has no any toxic and side effects. The raw material medicaments comprise 8 to 15 grams of pangolin, 8 to 15 grams of dragon's blood, 8 to 15 grams of safflower, 5 to 10 grams of angelica, 5 to 10 grams of rhizoma ligustici wallichii, 5 to 10 grams of spatholobus stem, 5 to 10 grams of ground beetle, 5 to 10 grams of teasel root, and 5 to 10 grams of processed radix aconiti.
Description
Technical field:
The invention belongs to external Chinese medicine, a kind of specifically external Chinese medicine that is used for the treatment of diseases such as hyperosteogeny, prolapse of lumbar intervertebral disc.
Background technology:
The medicine that diseases such as multiple treatment hyperosteogeny, prolapse of lumbar intervertebral disc are arranged on the market at present.Oral, effect is undesirable, and side effect is big, impairing the liver gallbladder taste etc.; The plaster of external, effect neither be fine, and skin is had stimulation, and allergic phenomena is arranged.
Summary of the invention:
The present invention is exactly at the problems referred to above, and a kind of good therapeutic effect that has is provided, treatment hyperosteogeny without any side effects, the external Chinese medicine of prolapse of lumbar intervertebral disc.
For realizing above-mentioned purpose of the present invention, the present invention adopts following technical scheme, and crude drug of the present invention consists of: Squama Manis 8-15 gram, Sanguis Draxonis 8-15 gram, Flos Carthami 8-15 gram, Radix Angelicae Sinensis 5-10 gram, Rhizoma Chuanxiong 5-10 gram, Caulis Spatholobi 5-10 gram, Eupolyphaga Seu Steleophaga 5-10 gram, Radix Dipsaci 5-10 gram, Radix Aconiti Preparata 5-10 gram.
Beneficial effect of the present invention:
1, without any side effects:
Chinese medicine of the present invention is made up of natural drug fully, relies on the direct osmosis of external used medicine, need not be oral, do not absorb by stomach; So, hinder less than the liver and gall taste;
2, good effect:
By the method for medicine external, can directly see through skin, close to focus, increase the intensity of topical remedy; Play blood circulation promoting and blood stasis dispelling, expelling wind and cold, reducing swelling and alleviating pain, promotion angiogenesis, absorb effects such as sequestrum, the new bone of formation;
3, indication is extensive:
Diseases such as Chinese medicine of the present invention is outstanding to hyperosteogeny (bony spur), prolapse of lumbar intervertebral disc, cervical spondylosis, cervical vertebra, arthritis, synovitis, knee nameless gall all have obvious effects;
The specific embodiment:
Above nine flavor crude drug are ground into Powdered, this powder is packed in the medicated bag, the size of medicated bag is advisable can cover focus.Medicated bag comprises front and back, and make by flexible material on the two sides, and the medicated bag back side directly contacts skin, and the flexible material at the medicated bag back side makes a spot of the infiltrating of medicated powder energy; And the flexible material in medicated bag front can not make medicated powder infiltrate.
The size of medicated bag is preferably 10 centimetres of 10 cm x, does not dally over one's work during the medication and learns.
The medicated bag front is the textile cloth of thick slightly point, and the medicated bag back side is the textile cloth of thin slightly point.
Embodiment 1:
Crude drug of the present invention consists of: Squama Manis 10 grams, Sanguis Draxonis 10 grams, Flos Carthami 15 grams, Radix Angelicae Sinensis 8 grams, Rhizoma Chuanxiong 8 grams, Caulis Spatholobi 6 grams, Eupolyphaga Seu Steleophaga 5 grams, Radix Dipsaci 10 grams, Radix Aconiti Preparata 8 grams.
Embodiment 2:
Crude drug of the present invention consists of: Squama Manis 15 grams, Sanguis Draxonis 10 grams, Flos Carthami 10 grams, Radix Angelicae Sinensis 8 grams, Rhizoma Chuanxiong 5 grams, Caulis Spatholobi 10 grams, Eupolyphaga Seu Steleophaga 5 grams, Radix Dipsaci 5 grams, Radix Aconiti Preparata 8 grams.
Embodiment 3:
Crude drug of the present invention consists of: Squama Manis 8 grams, Sanguis Draxonis 15 grams, Flos Carthami 15 grams, Radix Angelicae Sinensis 10 grams, Rhizoma Chuanxiong 9 grams, Caulis Spatholobi 7 grams, Eupolyphaga Seu Steleophaga 6 grams, Radix Dipsaci 6 grams, Radix Aconiti Preparata 8 grams.
Case 1 Ms Zhang, 55 years old, Shanghai Songjiang district silver is No. 18 building, 208 lanes, West Road all, mobile phone 13918385757
Clapped the X-ray sheet in hospital before 5 years and be diagnosed as knee joint hyperosteogeny, the symptom before the medication is that knee joint swells and ache, and it is constant to take action, and can not leave the bed; With Chinese medicine 5-6 of the present invention days with regard to pain relief, 1 month pain of medication disappears substantially, but also some is swollen, the freedom of movement of leaving the bed, 2 months all transference cures of medication, the same with healthy people.
Case 2 is revived certain, the chief cook of star hotel of ocean, Qinhuangdao, Hebei province, phone 15533501108
Hospital claps CT and is diagnosed as prolapse of lumbar intervertebral disc, and pain in the lumbar region has a pain in the leg (the lumbar vertebra pressuring nerve causes), can not work at all, subsists by eating antalgica; Just needn't eat antalgica on the 3rd day with Chinese medicine of the present invention, 2 months low backs of medication and lower limb are all thoroughly painful, go to work position again, and I require the reuse medicine to consolidate 2 months.
Case 3 Liu, people from Changchun, Jilin, phone 1323430578
Symptom before the medication is that cervical vertebra ache, pressuring nerve cause that the arm fiber crops are dizzy, cervical vertebra has sound, can only lean on the massage relief of symptoms on ordinary days; With Chinese medicine of the present invention one month, symptom obviously alleviated, and 2 months just thoroughly good, again need not do and massage.
Claims (4)
1, a kind of external Chinese medicine for the treatment of hyperosteogeny, prolapse of lumbar intervertebral disc, it is characterized in that crude drug of the present invention consists of: Squama Manis 8-15 gram, Sanguis Draxonis 8-15 gram, Flos Carthami 8-15 gram, Radix Angelicae Sinensis 5-10 gram, Rhizoma Chuanxiong 5-10 gram, Caulis Spatholobi 5-10 gram, Eupolyphaga Seu Steleophaga 5-10 gram, Radix Dipsaci 5-10 gram, Radix Aconiti Preparata 5-10 gram.
2, a kind of external Chinese medicine for the treatment of hyperosteogeny, prolapse of lumbar intervertebral disc according to claim 1 is characterized in that crude drug of the present invention consists of: Squama Manis 10 grams, Sanguis Draxonis 10 grams, Flos Carthami 15 grams, Radix Angelicae Sinensis 8 grams, Rhizoma Chuanxiong 8 grams, Caulis Spatholobi 6 grams, Eupolyphaga Seu Steleophaga 5 grams, Radix Dipsaci 10 grams, Radix Aconiti Preparata 8 grams.
3, a kind of external Chinese medicine for the treatment of hyperosteogeny, prolapse of lumbar intervertebral disc according to claim 1 is characterized in that crude drug of the present invention consists of: Squama Manis 15 grams, Sanguis Draxonis 10 grams, Flos Carthami 10 grams, Radix Angelicae Sinensis 8 grams, Rhizoma Chuanxiong 5 grams, Caulis Spatholobi 10 grams, Eupolyphaga Seu Steleophaga 5 grams, Radix Dipsaci 5 grams, Radix Aconiti Preparata 8 grams.
4, a kind of external Chinese medicine for the treatment of hyperosteogeny, prolapse of lumbar intervertebral disc according to claim 1 is characterized in that crude drug of the present invention consists of: Squama Manis 8 grams, Sanguis Draxonis 15 grams, Flos Carthami 15 grams, Radix Angelicae Sinensis 10 grams, Rhizoma Chuanxiong 9 grams, Caulis Spatholobi 7 grams, Eupolyphaga Seu Steleophaga 6 grams, Radix Dipsaci 6 grams, Radix Aconiti Preparata 8 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100113032A CN101530526B (en) | 2009-04-27 | 2009-04-27 | External Chinese medicament for treating hyperosteogeny and lumbar interveterbral disc protrusion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100113032A CN101530526B (en) | 2009-04-27 | 2009-04-27 | External Chinese medicament for treating hyperosteogeny and lumbar interveterbral disc protrusion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101530526A true CN101530526A (en) | 2009-09-16 |
| CN101530526B CN101530526B (en) | 2013-11-27 |
Family
ID=41101522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100113032A Expired - Fee Related CN101530526B (en) | 2009-04-27 | 2009-04-27 | External Chinese medicament for treating hyperosteogeny and lumbar interveterbral disc protrusion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101530526B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103028019A (en) * | 2011-09-30 | 2013-04-10 | 石兴国 | Bone health ointment |
| CN105055712A (en) * | 2015-08-13 | 2015-11-18 | 杨大妹 | Traditional Chinese medicine for treating lumbar disc herniation |
| CN107007668A (en) * | 2017-05-15 | 2017-08-04 | 郜占稳 | It is a kind of to treat plaster of cervical spondylopathy and preparation method thereof |
| CN107029155A (en) * | 2017-04-26 | 2017-08-11 | 尚正兰 | A kind of medicine for being used to treat cervical spondylopathy |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879723A (en) * | 2006-05-17 | 2006-12-20 | 苏娟 | Meridian obstruction dredging pills |
-
2009
- 2009-04-27 CN CN2009100113032A patent/CN101530526B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879723A (en) * | 2006-05-17 | 2006-12-20 | 苏娟 | Meridian obstruction dredging pills |
Non-Patent Citations (3)
| Title |
|---|
| 农勇安等: "中药治疗腰椎间盘突出症的近况及评价", 《颈腰痛杂志》 * |
| 薛怀宝等: "中医药治疗腰椎间盘突出症近况", 《贵阳中医学院学报》 * |
| 邰东旭等: "活血利水方治疗腰椎间盘突出症处方的筛选优化", 《中华中医药学刊》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103028019A (en) * | 2011-09-30 | 2013-04-10 | 石兴国 | Bone health ointment |
| CN103028019B (en) * | 2011-09-30 | 2015-06-03 | 石兴国 | Bone health ointment |
| CN105055712A (en) * | 2015-08-13 | 2015-11-18 | 杨大妹 | Traditional Chinese medicine for treating lumbar disc herniation |
| CN107029155A (en) * | 2017-04-26 | 2017-08-11 | 尚正兰 | A kind of medicine for being used to treat cervical spondylopathy |
| CN107007668A (en) * | 2017-05-15 | 2017-08-04 | 郜占稳 | It is a kind of to treat plaster of cervical spondylopathy and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101530526B (en) | 2013-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101837080B (en) | Topical ointment externally used for treating cervical spondylosis | |
| CN102600264B (en) | Externally-applied traditional Chinese medical composition for treatment of orthopedic diseases | |
| CN101530526B (en) | External Chinese medicament for treating hyperosteogeny and lumbar interveterbral disc protrusion | |
| CN103446264A (en) | Physical therapy liquid for treating neck-shoulder and lumbocrural pains and preparation method thereof | |
| CN101664455B (en) | Chinese medicinal composition for treating lumbago and preparation method | |
| CN102716254A (en) | Medicament for treating pain in heel and preparation method of medicament | |
| CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN102793888B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN103041108B (en) | Medicinal liquor and preparation method thereof | |
| CN102228584A (en) | Chinese medicinal preparation for treating helosis | |
| CN103877191B (en) | One treats osteoarticular medicine | |
| CN103720797B (en) | Foot bath external use traditional Chinese medicine for treating rheumatism | |
| CN102018858B (en) | Traditional Chinese medicine composition for treating sprain | |
| CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN101194985B (en) | Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny | |
| CN104055973A (en) | Traditional Chinese medicine liniment for treating rheumatoid bone diseases and arthralgia | |
| CN103933506A (en) | Externally-applied medicament for treating lumbar disc herniation | |
| CN103070997A (en) | Drug for curing ischialgia and preparing method thereof | |
| CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
| CN105943880A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN104435481A (en) | Traditional Chinese medicine formula for curing lumbar disc herniation | |
| CN105194411A (en) | Formula of traditional Chinese medicine for treating scapulobumeral periarthritis | |
| CN101991735A (en) | External-application ointment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131127 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |